Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Biogen’s tofersen fails to meet the primary goal in the Phase III ALS trialBiogen has announced that its investigational antisense drug, tofersen (BIIB067), flunked to meet the primary goal of...
Brickell Plans to Submit New Drug Application to FDA for gelBrickell Biotech will request the FDA in mid-2022 to approve its gel for excessive underarm sweating after decreasing sweat producti...
Pfizer tightens DMD patient criteria after serious adverse events in phase 3 gene therapy trialPfizer is tightening up the criteria for Duchenne muscular dystrophy patients to partake in phase...
Innovent, UNION Therapeutics Set to Advance Dermatology Market in China Innovent Biologics and UNION therapeutics have announced a strategic and licensing collaboration to develop and com...
Boston Scientific pays USD 336 Million to acquire blood clot medical device firmBoston Scientific Corp. is shelling out as much as USD 336 million to take over the rest of medical device firm ...
Win-win for Biogen as its Biosimilar Gets Approval for AMD Samsung Bioepis and Biogen's biosimilar drug, Byooviz, received USFDA approval for the treatment of vision loss, Age-related mac...
FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug Amylyx Pharmaceuticals has announced its plan to submit a New Drug Application (NDA) to the U.S. FDA for its drug, AMX0035 (sodi...
ADARx bags USD 75 Million to advance its RNA tech pipelineADARx Pharmaceuticals, a biotechnology company developing RNA targeting therapeutics, announced the completion of a USD 75 million Ser...
Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 BillionA collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will co...
Pfizer’s RSV Vaccine enters in the late-stage of clinical trials As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a ...
A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...
What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...
Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...
In advanced cancer patients, the most common site for the occurrence of metastasis is c...
Depression is a mental condition characterized by prolonged series of poor moods, loss ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
.png)
